Possible vaccine against COVID-2019 ready for Phase One trial
Around GMA
Around GMA
Still no buyer of Discaya’s Rolls-Royce with free umbrella at Customs 2nd auction A for A On Playlist Nearly P20M alleged smuggled cigarettes, shabu seized in Sultan KudaratArticle Inside Page
Showbiz News
Is mRNA-1273, the COVID-2019 vaccine, the world has been waiting for? Learn more about it HERE:
US-based biotech company Moderna Therapeutics has announced that its coronavirus vaccine is ready for Phase One trial, which is the first stage of testing in human subjects.
On February 24, Moderna Therapeutics made an announcement on their website:
“Vials of mRNA-1273 have been shipped to the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH) to be used in the planned Phase 1 study in the U.S.
mRNA-1273 is an mRNA vaccine against the novel coronavirus encoding for a prefusion stabilized form of the Spike (S) protein, which was selected by Moderna in collaboration with investigators at the NIAID Vaccine Research Center (VRC). Manufacture of this batch was funded by the Coalition for Epidemic Preparedness Innovations (CEPI).”
This breakthrough comes almost two months after China first alerted the World Health Organization about numerous cases of unusual pneumonia in Wuhan City in Hubei province, back on December 31, 2019. At that time, the Corona Virus Disease or COVID-19 was still unidentified.
And although the development of a candidate vaccine against COVID-2019 is great news, the world will have to wait until it has gone through all the stages of clinical trials and has been approved, for it to be made available for use.
For now, our best armors against COVID-2019 are intensive prevention measures and infection control.
